Parametric Portfolio Associates’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Parametric Portfolio Associates’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$14K	Sell	1,187 -769	-39%	-$13.8K	﹤0.01%	3665
2021 Q4	$64K	Sell	1,956 -433	-18%	-$17.5K	﹤0.01%	3589
2021 Q3	$107K	Buy	2,389 +478	+25%	+$23.3K	﹤0.01%	3527
2021 Q2	$104K	Buy	+1,911	New	+$113K	﹤0.01%	3478
2021 Q1	–	Sell	-1,889	Closed	-$205K	–	4089
2020 Q4	$205K	Sell	1,889 -3,264	-63%	-$298K	﹤0.01%	3765
2020 Q3	$456K	Buy	+5,153	New	+$585K	﹤0.01%	3317

Other funds holding SYRS

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Ally Bridge Group New York $101M AUM 249.88% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return